Advertisement
Advertisement
NUVB
Nuvation Bio Inc.
4.39
USDSponsored
+0.01
+0.34%
Mar 26, 15:08 UTC -4
Open
NUVB Earnings Reports
Positive Surprise Ratio
NUVB beat 13 of 20 last estimates.
65%
Next Report
Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
$54.68M
/$0.00
Implied change from Q4 25 (Revenue/ EPS)
+30.61%
/-100.00%
Implied change from Q1 25 (Revenue/ EPS)
+1673.04%
/-100.00%
Nuvation Bio Inc. earnings per share and revenue
On Mar 02, 2026, NUVB reported earnings of -0.11 USD per share (EPS) for Q4 25, missing the estimate of -0.09 USD, resulting in a -20.75% surprise. Revenue reached 41.87 million, compared to an expected 38.07 million, with a 9.96% difference. The market reacted with a +1.39% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 8 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 54.68 million USD, implying an decrease of -100.00% EPS, and increase of 30.61% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Absci Corporation Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.23
Surprise
-16.04%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
LENZ Therapeutics, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.99
Actual
-$1.15
Surprise
-17.10%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.03
Actual
-$0.11
Surprise
-408.12%
Equillium, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+35.28%
MaxCyte, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
TELA Bio, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.12%
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
FAQ
What were Nuvation Bio Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Nuvation Bio Inc. reported EPS of -$0.11, missing estimates by -20.75%, and revenue of $41.87M, 9.96% above expectations.
How did the market react to Nuvation Bio Inc.'s Q4 2025 earnings?
The stock price moved up 1.39%, changed from $6.46 before the earnings release to $6.55 the day after.
When is Nuvation Bio Inc. expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for Nuvation Bio Inc.'s next earnings report?
Based on 8
analysts, Nuvation Bio Inc. is expected to report EPS of -- and revenue of $54.68M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement